Diaceutics PLC (AIM: DXRX)
London
· Delayed Price · Currency is GBP · Price in GBX
147.15
+0.15 (0.10%)
Jan 21, 2025, 12:33 PM GMT+1
Diaceutics Revenue
Diaceutics had revenue of 12.32M GBP in the half year ending June 30, 2024, with 63.66% growth. This brings the company's revenue in the last twelve months to 26.10M, up 19.16% year-over-year. In the year 2023, Diaceutics had annual revenue of 23.70M with 21.51% growth.
Revenue (ttm)
26.10M
Revenue Growth
+19.16%
P/S Ratio
4.75
Revenue / Employee
141.82K
Employees
184
Market Cap
124.24M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23.70M | 4.20M | 21.51% |
Dec 31, 2022 | 19.50M | 5.56M | 39.88% |
Dec 31, 2021 | 13.94M | 1.25M | 9.82% |
Dec 31, 2020 | 12.70M | -746.00K | -5.55% |
Dec 31, 2019 | 13.44M | 3.07M | 29.58% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |